Endo International plc

306 articles about Endo International plc

• Endo International Announces Proposed Private Offering Of Senior Secured Notes

  4/11/2017

• Endo International Announces Plan To Refinance Existing Credit Agreement

  4/5/2017

• Endo International Statement On FDA Advisory Committees' Vote Related To OPANA ER

  3/15/2017

• Endo International To Delist Ordinary Shares From The Toronto Stock Exchange

  3/6/2017

• Endo International Reports Fourth-Quarter And Full-Year 2016 Financial Results

  2/28/2017

• Endo International To Announce Fourth-Quarter And Full-Year 2016 Financial Results

  2/13/2017

• Endo International Announces U.S. FDA Approval Of Ephedrine Sulfate Injection, USP

  1/31/2017

• Endo International Eliminates 90 Jobs in Restructuring

  1/26/2017

• Endo International Release: Pharma Announces Agreement To Resolve FTC Investigation And Litigation

  1/24/2017

• Former Sanofi and Lupin Pharmaceuticals, Inc. Execs Jump to Endo International

  12/21/2016

• Endo International Announces Appointment Of Blaise Coleman As Chief Financial Officer

  12/20/2016

• Endo International Begins Shipment of Generic ZETIA

  12/12/2016

• Endo International Cuts 375-Member U.S. Branded Pain Sales Field Force

  12/8/2016

• Endo International Begins Shipment Of Generic CellCept

  12/6/2016

• Endo International Announces Positive Data From Phase 2b Study Of Collagenase Clostridium Histolyticum (CCH) In Patients With Cellulite

  11/17/2016

• Endo International Warns Of More Pressure On Generics Business In 2017

  11/9/2016

• Endo International Reports Third Quarter 2016 Financial Results

  11/9/2016

• Endo International Strengthens Leadership Team With Appointment Of Two Key Executives

  11/7/2016

• Endo International's Qualitest to Lay Off 300 in Shuttering of Its North Carolina Facility

  11/4/2016

• Endo International Begins Shipment Of Generic SEROQUEL XR

  11/1/2016